In Brief: SmithKline Beecham's Kytril
Executive Summary
SmithKline Beecham's Kytril: Pediatric supplement approved Jan. 21 for the anti-emetic includes results from a study evaluating single I.V. dose of 40 mcg/kg in pediatric patients receiving chemotherapy. Another Kytril sNDA approved at the same time provides for 30-second infusion as alternative to the currently-approved five-minute infusion time...